OR WAIT null SECS
January 04, 2023
Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.
PK/PD studies are a crucial tool in the successful development of biologics.
December 19, 2022
The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.
December 12, 2022
The R&D analytical solutions will consist of analytical lab services that use USP’s in-house scientific expertise and state-of-the-art facilities at the USP Advanced Manufacturing Technology Lab in Richmond and the USP headquarters facility in Rockville, Md.
December 07, 2022
One can improve method precision and productivity by replacing one step in sample preparation with an automated approach.
Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
November 21, 2022
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
November 02, 2022
Replacing a step in sample preparation with an automated approach improves both method precision and productivity.
Single-use systems can benefit from standardized risk assessment and analysis protocols, which can facilitate the way in which processing equipment components are compared.